Call for Abstracts

Abstract submissions are invited for this Congress and will be published as a supplement by the Journal of the International AIDS Society.

To submit an abstract please click here.
Please note when clicking the above link you will be leaving the HIV Glasgow Congress website and will be taken to our third party abstract submission site.

The deadline for receipt of abstracts is 6 July 2018. Full details including submission criteria and deadlines are available here.

Individuals wishing to submit a late breaker will be able to do so by providing a letter of intent to [email protected] that is received by the regular abstract deadline of Friday 6 July. The late breaker abstract must contain new information / data and the final abstract must be received by Friday 17 August to be considered by the Congress Scientific Committee. The letter of intent should include a working title for the abstract, a brief description of the proposed content and the reason(s) why it is not possible to submit by the 6 July deadline.

Abstract submission categories are in line with the main programme themes of the congress.

Abstract Categories

ARV-based Prevention
– Mother to-child transmission
– PEP
– PrEP
– Treatment as Prevention (TasP)
Treatment Strategies and outcomes
– New Treatments and Targets
– Target Populations
– Adolescents and Children
– Women
– Late Presenters
– Naive Patients
– Primary Infection
– Experienced Patients
– IDUs
– Strategies
– Adherence
– Cure
– Simplification
– Switch Studies
– Other
Opportunistic Infections
– Tuberculosis
– Others
Co-morbidities and complications of disease and/or treatment
– Ageing
– Bone
– Cardiovascular
– Malignancies: AIDS-defining and Non-AIDS-defining
– Metabolic
– Neurological
– Renal
– Other
Viral Hepatitis
Clinical Pharmacology
Community Initiatives
Models of Care
– Cost Effectiveness
– Evaluation of ARV Delivery and Coverage
Virology and Immunology
– Biomarkers
– Tropism
– Resistance
– Other

If a submitted abstract is accepted for presentation, one of the authors on the abstract will be required to register for the congress and present the abstract. All abstracts will be considered for either oral or poster presentation unless you specifically opt for ‘poster only’ during the submission process.

Given the focus of this meeting and the single-session format, abstracts are more likely to be
accepted if they contain clinically relevant information in line with the Congress theme

Exceptionally, abstracts which have only previously been presented at national or regional
meetings will be considered for this meeting if the abstract is perceived by the abstract
reviewers as being of high value to a broader audience

Abstracts previously presented or published at international congresses will only be considered
if they contain new or updated information.

Individuals opting to submit abstracts previously presented will be asked to tick a box on the abstract submission form indicating whether the abstract has previously been accepted at a national/regional or international meeting, and to provide information on the meeting it was accepted for.

Abstracts from the previous Congress are available on-line through the Previous Congresses section of this site.